305 related articles for article (PubMed ID: 1651757)
1. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L
Br J Obstet Gynaecol; 1991 Jun; 98(6):550-7. PubMed ID: 1651757
[TBL] [Abstract][Full Text] [Related]
2. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
3. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
4. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.
Turan T; Karacay O; Tulunay G; Boran N; Koc S; Bozok S; Kose MF
Int J Gynecol Cancer; 2006; 16(3):1432-8. PubMed ID: 16803542
[TBL] [Abstract][Full Text] [Related]
5. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA
Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675
[TBL] [Abstract][Full Text] [Related]
6. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984).
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L; Dent J
Br J Obstet Gynaecol; 1986 Jan; 93(1):63-9. PubMed ID: 3002420
[TBL] [Abstract][Full Text] [Related]
7. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
8. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
9. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Bower M; Newlands ES; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
J Clin Oncol; 1997 Jul; 15(7):2636-43. PubMed ID: 9215835
[TBL] [Abstract][Full Text] [Related]
10. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Mao Y; Wan X; Lv W; Xie X
Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
[TBL] [Abstract][Full Text] [Related]
11. The management of high-risk gestational trophoblastic tumours (GTT).
Newlands ES; Bower M; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S65-70. PubMed ID: 9833617
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
13. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
14. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
15. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, dactinomycin, vincristine, and cyclophosphamide.
Gallion HH; van Nagell JR; Donaldson ES; Higgins RV
Gynecol Oncol; 1989 Jul; 34(1):98-100. PubMed ID: 2544491
[TBL] [Abstract][Full Text] [Related]
16. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).
Bolis G; Bonazzi C; Landoni F; Mangili G; Vergadoro F; Zanaboni F; Mangioni C
Gynecol Oncol; 1988 Nov; 31(3):439-44. PubMed ID: 2846414
[TBL] [Abstract][Full Text] [Related]
17. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Cagayan MS
J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
[TBL] [Abstract][Full Text] [Related]
18. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
[TBL] [Abstract][Full Text] [Related]
19. Management of high-risk gestational trophoblastic disease.
Lurain JR
J Reprod Med; 1998 Jan; 43(1):44-52. PubMed ID: 9475149
[TBL] [Abstract][Full Text] [Related]
20. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
